Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001947620-23-000001
Filing Date
2023-04-27
Accepted
2023-04-27 12:52:14
Documents
1
Effectiveness Date
2023-04-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5759
  Complete submission text file 0001947620-23-000001.txt   6819
Mailing Address 75 KNEELAND STREET 14TH FLOOR BOSTON MA 02111
Business Address 75 KNEELAND STREET 14TH FLOOR BOSTON MA 02111 1 (617) 766-3909
Lapix Therapeutics Inc. (Filer) CIK: 0001947620 (see all company filings)

EIN.: 842410144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-480185 | Film No.: 23854001